Anticoagulation in Patients with Platelet Disorders

Carlo Zaninetti, Thomas Thiele

Research output: Contribution to journalReview articlepeer-review

Abstract

Platelet disorders comprise heterogeneous diseases featured by reduced platelet counts and/or impaired platelet function causing variable bleeding symptoms. Despite their bleeding diathesis, patients with platelet disorders can develop transient or permanent prothrombotic conditions that necessitate prophylactic or therapeutic anticoagulation. Anticoagulation in patients with platelet disorders is a matter of concern because the bleeding risk could add to the hemorrhagic risk related to the platelet defect. This review provides an overview on the evidence on anticoagulation in patients with acquired and inherited thrombocytopenia and/or platelet dysfunction. We summarize tools to evaluate and balance bleeding- and thrombotic risks and describe a practical approach on how to manage these patients if they have an indication for prophylactic or therapeutic anticoagulation.

Original languageEnglish
Article number20110078
Pages (from-to)112-119
Number of pages8
JournalHamostaseologie
Volume41
Issue number2
DOIs
Publication statusPublished - Apr 1 2021
Externally publishedYes

Keywords

  • anticoagulation
  • bleeding risk
  • platelet dysfunction
  • thrombocytopenia
  • thrombotic risk

ASJC Scopus subject areas

  • Hematology

Fingerprint

Dive into the research topics of 'Anticoagulation in Patients with Platelet Disorders'. Together they form a unique fingerprint.

Cite this